National Heart, Lung, and Blood Institute, NIH, HLVD Contracts Section, 6701 ROCKLEDGE DR MSC7902, BETHESDA MD 20892-7902

A -- ACUTE RESPIRATORY DISTRESS SYNDROME NETWORK POC Dorothy Berlin Gail, Ph.D., Director, Lung Biology and Disease Program, (301) 435-0222. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network, a group of 10 academic medical centers consisting of 24 hospitals with expertise in clinical research relating to acute adult lung injury, invites letters of interest by December 1, 1996, from private sector companies who have developed novel therapies for acute lung injury and/or acute respiratory distress syndrome (ARDS) and who are interested in collaborating in Phase II or Phase III clinical trials. Letters of interest will not be viewed as a formal commitment, but are invited as a first step in exploring possible future collaborations. Information submitted will be treated as strictly confidential. Letters of interest should include a proposal regarding the nature of possible interactions with the ARDS Network. Network investigators and NHLBI staff will select agents for study based on scientific interest and promise, novelty, feasibility, and availability. Cost and possible financial support may also enter into the decision. It is anticipated that clinical trials of agents selected will be initiated as early as 1997, but later starting dates will also be considered. Send letters, by December 1, 1996, and questions to Dorothy Berlin Gail, Ph.D., Director, Lung Biology and Disease Program, Division of Lung Diseases, NHLBI, 6701 Rockledge Drive Room 10100, Bethesda, Maryland 20892-7952, (301) 435-0222. (0311)

Loren Data Corp. http://www.ld.com (SYN# 0012 19961107\A-0012.SOL)